Efficacy of post-induction therapy for high-risk neuroblastoma patients with end-induction residual disease.
Ami Vijay DesaiMark A ApplebaumTheodore G KarrisonAkosua OppongCindy YuanKatherine R BergKyle L MacQuarrieElizabeth A SokolAnurekha G HallNavin PintoIan WolfeRajen ModySuzanne ShustermanValeria SmithJennifer H FosterMichele NassinJames L LaBelleRochelle BagatellSusan L CohnPublished in: Cancer (2022)
Prospective studies to confirm the benefits of bridge treatment and the prognostic significance of metastatic response observed in this study are warranted.